Literature DB >> 29212777

Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma.

Simon Garinet1, Juliette Nectoux2, Mario Neou1, Eric Pasmant2,3, Anne Jouinot1,4, Mathilde Sibony5, Lucie Orhant2, Juliana Pipoli da Fonseca6, Karine Perlemoine1, Léopoldine Bricaire7, Lionel Groussin1,7, Olivier Soubrane8, Bertrand Dousset9, Rossella Libe1,7, Franck Letourneur6, Jérome Bertherat1,7,10, Guillaume Assié1,7,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29212777     DOI： 10.1530/ERC-17-0467

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  9 in total

1.  New strategies for applying targeted therapies to adrenocortical carcinoma.

Authors:  Dipika R Mohan; Antonio Marcondes Lerario; Isabella Finco; Gary D Hammer
Journal:  Curr Opin Endocr Metab Res       Date:  2019-08-06

Review 2.  Adrenocortical carcinoma - towards genomics guided clinical care.

Authors:  Joakim Crona; Felix Beuschlein
Journal:  Nat Rev Endocrinol       Date:  2019-09       Impact factor: 43.330

Review 3.  Advances in adrenal tumors 2018.

Authors:  J Crona; F Beuschlein; K Pacak; B Skogseid
Journal:  Endocr Relat Cancer       Date:  2018-07       Impact factor: 5.678

4.  Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases.

Authors:  Mark J McCabe; Mark Pinese; Chia-Ling Chan; Nisa Sheriff; Tanya J Thompson; John Grady; Marie Wong; Marie-Emilie A Gauthier; Clare Puttick; Velimir Gayevskiy; Elektra Hajdu; Stephen Q Wong; Wade Barrett; Peter Earls; Robyn Lukeis; Yuen Y Cheng; Ruby C Y Lin; David M Thomas; D Neil Watkins; Marcel E Dinger; Ann I McCormack; Mark J Cowley
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-04-01

Review 5.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

Review 6.  Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers.

Authors:  Yuling Cheng; Wei Kou; Dandan Zhu; Xinbo Yu; Yu Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555

7.  Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.

Authors:  Bassel Nazha; Tony Z Zhuang; Hiba I Dada; Leylah M Drusbosky; Jacqueline T Brown; Deepak Ravindranathan; Bradley C Carthon; Omer Kucuk; Jamie Goldman; Viraj A Master; Mehmet Asim Bilen
Journal:  Oncologist       Date:  2022-06-08       Impact factor: 5.837

Review 8.  Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?

Authors:  Pál Perge; Gábor Nyirő; Bálint Vékony; Peter Igaz
Journal:  Endocrine       Date:  2022-05-13       Impact factor: 3.925

9.  Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma.

Authors:  M Laganà; S Grisanti; R Ambrosini; D Cosentini; A Abate; M Zamparini; V D Ferrari; A Gianoncelli; A Turla; L Canu; M Terzolo; G A M Tiberio; S Sigala; A Berruti
Journal:  ESMO Open       Date:  2022-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.